Skip to content
Try Mental Wellness – Lifestyle
Author:
Whitehawk Therapeutics
Whitehawk Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
May 7, 2026
Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026
April 19, 2026
Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series
April 16, 2026
Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026
April 10, 2026
←
Previous Page
1
2